Clinical trial
Combigan Ophthalmic Solution(Brimonidine 0.2% and Timolol 0.5%)With Latanoprost…
NCT00442312 · Genovate Biotechnology Co., Ltd.,, Industry · Unknown status
Key facts
| NCT number | NCT00442312 |
|---|---|
| Title | Combigan Ophthalmic Solution(Brimonidine 0.2% and Timolol 0.5%)With Latanoprost Compared With Latanoprost Monotherapy |
| Official title | An Open Label,Switch Study of the Safety and Efficacy of Combigan Ophthalmic Solution(Brimonidine 0.2% and Timolol 0.5%)With Latanoprost Compared With Latanoprost Monotherapy in Patient With Glaucoma or Ocular Hypertension. |
| Lead sponsor | Genovate Biotechnology Co., Ltd.,, Industry |
| Collaborators | Allergan Medical Industry |
| Status | Unknown status |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Glaucoma |
| Intervention type | Drug |
| Interventions | Combigan Ophthalmic Solutiom |
| Enrollment | 43 |
| Start date | May 1, 2006 |
| Completion | Nov 1, 2006 |
| First posted | Mar 1, 2007 |
| Last update posted | Mar 1, 2007 |
| Countries | Taiwan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: